Rho-kinase (ROCK-I or ROCKβ and ROCK-II or ROCKα) is the downstream effector of RhoA and constitutes the RhoA/ROCK signal pathway involved in pulmonary endothelial dysfunction in healthy smokers [21] and patients with COPD [22]. This evidence concerns the gene RHOA and chronic obstructive pulmonary disease.